4th Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$51,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA user fee agreements, S. 296 Preserving Access to Life-Saving Medications Act; and HR 2245 Preserving Access to Life-Saving Medications Act of 2011, S. 1882 Fair And Immediate Release of Generic Drugs Act, importation of prescription drugs (amendment HR 2112)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President (2002-2005) |
Medicare/Medicaid MMM
HR 3342/S. 1356 Affordable Medicines Act of 2011; Medicaid Drug Rebates
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President (2002-2005) |
Labor Issues/Antitrust/Workplace LBR
S. 27 Preserve Access to Generic Drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President (2002-2005) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.